In 2023, Richards and his colleagues published a comparison between patients taking semaglutide and those using lisdexamfetamine and topiramate, a combination medication already approved for binge eating or weight loss
Professional Guidance at Aestha Clinic Our comprehensive approach to GLP-1 therapy encompasses thorough initial patient assessment, individualised dosing protocols, and regular monitoring with adjustment as needed
The active ingredient in semaglutide reaches peak blood levels about 2448 hours after injection, meaning the time of day you inject has minimal impact on the medication's effectiveness
For those struggling with obesity, weight loss medications are often top of mind
In addition, glucagon-like peptide-1 analogues (GLP-1a) have garnered increased attention as pharmacological treatments capable of improving cognitive functions, supported by positive results from preclinical studies and some observational research [6, 7]
.png)
